SELECT LANGUAGE BELOW

Drugmaker caps its inhalers at $35 a month 

boehringer ingelheim announced that starting June 1, all inhaler products will be capped at $35 per month. This is aimed at patients with employer-sponsored insurance and the underinsured and uninsured. This comes about two months after Democratic senators sent their report. letter To America’s top inhaler manufacturer — AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Teva — […]

Why weakness in small caps may be a short-term setback – CNBC

Small-cap stocks may be on the cusp of a turnaround. The Russell 2000's underperformance so far this year is likely to recede in the short term, said Katie Stockton, market technician at Fairlead Strategies. “We have some confidence that small-cap stocks are going to do better. They probably won't outperform by a lot, but it's […]